Estimates Revisions Corbus Pharmaceuticals Holdings, Inc. Deutsche Boerse AG
Stocks
3371
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:02:09 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 9.555 EUR | -0.62% |
|
+3.19% | +43.68% |
| 08-13 | Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating | MT |
| 08-07 | Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Select your edition
All financial news and data tailored to specific country editions
